Novel crystalline forms of antidiabetic compounds

Details for Australian Patent Application No. 2006223411 (hide)

Owner Merck & Co., Inc.

Inventors Zhao, Dalian; Leyes, Aquiles E.; Boardman, David; Marcoux, Jean-Francois

Agent Spruson & Ferguson

Pub. Number AU-A-2006223411

PCT Pub. Number WO2006/099077

Priority 60/660,476 10.03.05 US

Filing date 10 March 2006

Wipo publication date 21 September 2006

International Classifications

C07D 209/10 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A01N 43/38 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/099077 Priority application(s): WO2006/099077

11 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006223412-High flux, microporous, sieving membranes and separators containing such membranes and processes using such membranes

2006223410-Method for implementing required navigational performance procedures